Last Updated: June 24, 2026

FIRVANQ Drug Patent Profile

Name: FIRVANQ Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Firvanq patents expire, and what generic alternatives are available?

Firvanq is a drug marketed by Azurity and is included in one NDA. There are seven patents protecting this drug.

The generic ingredient in FIRVANQ is vancomycin hydrochloride. There are twenty-two drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the vancomycin hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Firvanq

A generic version of FIRVANQ was approved as vancomycin hydrochloride by FRESENIUS KABI USA on March 17^th, 1987.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for FIRVANQ?
What are the global sales for FIRVANQ?
What is Average Wholesale Price for FIRVANQ?

Summary for FIRVANQ

US Patents:	0
Applicants:	1
NDAs:	1
Drug Prices:	Drug price information for FIRVANQ
What excipients (inactive ingredients) are in FIRVANQ?	FIRVANQ excipients list
DailyMed Link:	FIRVANQ at DailyMed

Drug patent expirations by year for FIRVANQ

US Patents and Regulatory Information for FIRVANQ

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Azurity	FIRVANQ KIT	vancomycin hydrochloride	FOR SOLUTION;ORAL	208910-001	Jan 26, 2018	AA	RX	Yes	Yes	10,959,947	⤷ Start Trial	Y			⤷ Start Trial
Azurity	FIRVANQ KIT	vancomycin hydrochloride	FOR SOLUTION;ORAL	208910-002	Jan 26, 2018	AA	RX	Yes	Yes	10,493,028	⤷ Start Trial	Y			⤷ Start Trial
Azurity	FIRVANQ KIT	vancomycin hydrochloride	FOR SOLUTION;ORAL	208910-001	Jan 26, 2018	AA	RX	Yes	Yes	10,688,046	⤷ Start Trial	Y			⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.